Categories: All postsAnalysts

Analyst ups his price target on KITS Eyecare

Ventum Capital Markets analyst Devin Schilling raised his price target on KITS Eyecare (KITS Eyecare Stock Quote, Chart, News, Analysts, Financials TSXV:KITS) to $18.00 from $16.00 in a May 27 note, reiterating his “buy” rating and calling the company a “must-own name” following investor meetings that reinforced confidence in its growth and execution strategy.

KITS is a Canadian company that sells eyeglasses and contact lenses online, handling the entire process from production to delivery.

The company has averaged 32% revenue growth per quarter over the past 10 quarters and increased its EBITDA margin from 1.7% to 7.4% during that period.

“As impressive as this is, we see the growth trajectory continuing with expectations that KITS will approach C$250M in revenue by 2026 and C$500M by 2029,” Schilling said. “Furthermore, we also see EBITDA margins trending to 10% over the medium term and surpassing 15% by 2029, driven by an improving product mix and further operating leverage. KITS believes that higher margin glasses will eventually represent 30-40% of the product mix (up from 14% today).”

Schilling thinks that Kits will generate $11.3-million in Adjusted EBITDA on revenue of $200.0-million in fiscal 2025. He expects those numbers to improve to $14.9-million in EBITDA on $236.6-million in revenue in fiscal 2026.

Macro challenges are creating opportunities, Schilling said, and KITS plans to use the current economic climate to gain market share by appealing to more value-conscious customers.

“In doing so, KITS will increase marketing spend in Q2, which is anticipated to reduce EBITDA margins during the upcoming quarter,” he said. “We note that new customers tend to be lower margin for KITS at the onset but often repeat purchase with higher average order values and more favourable margins over the longer term. We are supportive of this strategy and see potential upside to our H2 EBITDA margin forecast of 5.6%.”

-30-

Tagged with: kits
Rod Weatherbie

Rod Weatherbie is a journalist based in Prince Edward Island. Since 2004, he has written extensively about the Canadian property and casualty insurance landscape. He was also a founder and contributing editor for a Toronto-based arts website and a PEI-based food magazine. His fiction and poetry have been featured in The Fiddlehead, The Antigonish Review, and Juniper.

Recent Posts

Can you make money with Metatek-Group stock?

Metatek-Group’s (Metatek-Group Stock Quote, Chart, News, Analysts, Financials TSX:MTEK) strong sequential revenue growth and expectations for a further improvement in… [Read More]

10 hours ago

Ascend Wellness Holdings: Buy, Sell or Hold?

Ascend Wellness Holdings’ (Ascend Wellness Holdings Stock Quote, Chart, News, Analysts, Financials CSE:AAWH.U) return to year-over-year revenue growth and improving… [Read More]

11 hours ago

RBC raises price target on Tidewater Renewables to $31.00

RBC Capital Markets analyst Maurice Choy raised his target on Tidewater Renewables (Tidewater Renewables Stock Quote, Chart, News, Analysts, Financials… [Read More]

11 hours ago

Apotex Health: this analyst just raised his price target

RBC Capital Markets analyst Douglas Miehm raised his target for Apotex Health (Apotex Health Stock Quote, Chart, News, Analysts, Financials… [Read More]

11 hours ago

Magellan Aerospace: Buy, Sell or Hold?

Magellan Aerospace’s (Magellan Aerospace Corp. Stock Quote, Chart, News, Analysts, Financials TSX:MAL) stronger-than-expected third-quarter results and potential opportunities from increased… [Read More]

11 hours ago

Is Cargojet (TSX:CJT) a buy right now?

Cargojet's (Cargojet Stock Quote, Chart, News, Analysts, Financials TSX:CJT) stronger-than-expected third-quarter results and ability to maintain margins despite higher fuel… [Read More]

11 hours ago